Product Images Pregabalin

This text provides information on the percentage of patients improved with different doses of Pregabalin as compared to a placebo. It shows the varying levels of improvement in pain from baseline for each dosage regimen.*

This text presents the comparison of the percent of patients improved with Pregabalin 100 mg three times a day versus Placebo. It shows the percent improvement in pain from the baseline for different levels, ranging from 210 to 290. The data provides insights into the effectiveness of Pregabalin in managing pain compared to a placebo.*

This text provides information about the percent of patients improved with different dosages of Pregabalin (200 mg and 100 mg three times a day) compared to a placebo. The data shows the percent improvement in pain from baseline at various points. The results are presented in a numerical format showing the improvement trend.*

This text provides data on the percent of patients improved for Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and Placebo. It also shows the percent improvement in pain from the baseline. The numbers indicate the percentage of patients showing improvement with different medication dosages and the placebo.*

The text does not provide any useful description.*

This is a comparison of responder rates in a study involving different dosages of a medication. The placebo group had a responder rate of 40.6%, while the groups receiving 2.5 mg/kg/day and 10 mg/kg/day of the medication had responder rates of 29.1% and 22.6% respectively. The study included 93 participants in the 2.5 mg/kg/day group, 103 participants in the 10 mg/kg/day group, and 96 participants in the placebo group.*

This is a table showing the percentage of patients who improved in pain with different daily doses of Pregabalin compared to a placebo. The doses evaluated are 600mg, 450mg, and 300mg daily. The results show that a higher dose of Pregabalin generally resulted in a higher percentage of patients showing improvement in pain compared to a lower dose or placebo.*

This text provides information on the percentage of subjects improved from baseline to week 12 under the placebo and pregabalin treatments. The data shows that 100% of subjects improved with pregabalin compared to the placebo. The values of 210, 220, 230, 240, 250, 260, and 270 are also provided, but their specific relevance is not clear from the text.*

This text provides data on the percentage of subjects who improved from baseline to week 16 under the drug Pregabalin compared to Placebo. The percentage increment is shown on a scale graphically which ranges from 0 to 100.*

Description: This text is labeling information for Pregabalin capsules containing 25 mg, with details on storage conditions, dosage, manufacturer, and contact information. It advises dispensing in child-resistant containers at controlled room temperature. The capsules are manufactured by Eskayef Pharmaceuticals in Bangladesh for Westminster Pharmaceuticals in Tennessee. The text also indicates the presence of an accompanying prescribing information leaflet for patients.*

This text provides information on a medication labeled as "Pregabalin Capsules," each containing 50 mg of pregabalin. The typical dosage and storage instructions are given. The medication guide is to be dispensed with each patient's prescription. The manufacturing details include SK-F as the manufacturer located in Bangladesh, and the product is distributed by Westminster Pharmaceuticals, LLC in Nashville, TN. For any inquiries, a toll-free number is provided.*

This text provides information about a medication called Pregabalin in capsule form. Each capsule contains 75 mg. The manufacturer is Westminster Pharmaceuticals, LLC based in Nashville, Tennessee. The usual dosage information is included, along with contact details for inquiries. It is advised to store the capsules at a temperature range of 20°C to 25°C (68°F to 77°F). Dispensing and storage instructions are also highlighted. Additionally, the pharmaceutical company SK+F is mentioned as involved in the manufacturing process. The text also indicates that 90 capsules are included in the package.*

This text appears to be a medication label for a capsule containing 100 mg of Pregabalin, USP. The usual dosage instructions can be found in the accompanying prescribing information. It is advised to store the capsules in a tight, child-resistant container at a temperature between 20° to 25° C (68° to 77° F), with excursions permitted between 15° to 30° C (59° to 86° F). The medication is manufactured by Eskayef Pharmaceuticals Limited in Bangladesh and distributed by Westminster Pharmaceuticals, LLC in Nashville, TN. Pharmacists are instructed to dispense the accompanying Medication Guide to each patient.*

The text mentions a capsule containing 150 mg of pregabalin, manufactured for Westminster Pharmaceuticals in Nashville, Tennessee. The usual dosage information can be found on the packaging, along with a toll-free number for inquiries. It also provides details on storage conditions, such as storing at 20° to 25°C (68° to 77°F) in a child-resistant container. The manufacturer is listed as ESKAYEF PHARMACEUTICALS LIMITED in Bangladesh. Additional information is available in the prescribing information and a medication guide.*

The text mentions that each capsule contains 200 mg of pregabalin, USP, and provides contact information for Westminster Pharmaceuticals, LLC. It also includes storage instructions to keep the capsules in a tight, child-resistant container at a temperature range of 20 to 25 degrees Celsius. The text further instructs pharmacists to dispense the accompanying Medication Guide to each patient and mentions that the capsules are manufactured by Eskayef Pharmaceuticals Limited in Bangladesh.*

Each capsule of LDIEETy Bk RVl contains 225 mg pregabalin, USP. The medication is dispensed in child-resistant containers and should be stored between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The prescribing information should be consulted for dosage details. This product is manufactured by Eskayef Pharmaceuticals Limited in Bangladesh and distributed by Westminster Pharmaceuticals in Nashville, TN. The pharmacist should dispense the medication along with the accompanying Medication Guide for each patient.*

This text provides information on a medication called Pregabalin, with each capsule containing 300 mg of the substance. It mentions the manufacturer as Westminster Pharmaceuticals, LLC and provides a toll-free number for inquiries. The usual dosage information should be obtained from the prescribing information. The text also includes storage instructions, contact details for pharmacists, and details about the company responsible for manufacturing the capsules. The medication guide should be dispensed to each patient. The medication is packaged in containers designed to be child-resistant.*